Histological and ultra structural study of 5-fluorouracil-induced small intestinal mucosal damage in rats

Asian Journal of Cell Biology

Volumn 8, Issue 1, 2013, Pages 1-21

  Gawish, S A Abou Elez ^a   Nosseir, D A ^a   Omar, N M ^a   Sarhan, N M R ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

5 fluorouracil; Small intestine; Ultrastructure

Indexed keywords

RATTUS;

EID: 84878422573     PISSN: 18140068     EISSN: None     Source Type: Journal    
DOI: 10.3923/ajcb.2013.1.21     Document Type: Article

References (28)

1. Cabana, E.M., 1999. Cellular degeneration and infiltration. Pathology notes Dr. EM Cabana home on the www. http://www2.mozcom.com/~emcdvm/.
2. Cameron, S., A. Schwartz, S. Sultan, I.M. Schaefer and R. Hermann et al, 2012. Radiation-induced damage in different segments of the rat intestine after external beam irradiation of the liver. Exp. Mol. Pathol, 92: 243-258.
3. Carneiro-Filho, B.A., I.P.F. Lima, D.H. Araujo, M.C. Cavalcante and G.H.P. Carvalho et al, 2004. Intestinal barrier function and secretion in methotrexate-induced rat intestinal mucositis. Digestive Dis. Sci., 49: 65-72.
4. Duncan, M. and G. Grant, 2003. Oral and intestinal mucositis-causes and possible treatments. Aliment. Pharmacol. Ther., 18: 853-874.
5. Fata, F., I.G. Ron, N. Kemeny, E. O'Reilly, D. Klimstra and D.P. Kelsen, 1999. 5-Fluorouracilinduced small bowel toxicity in patients with colorectal carcinoma. Cancer, 86: 1129-1134.
6. Gamble, M. and L. Wilson, 2002. The Heniatoxylin and Eosin. In: Theory and Practice of Histological Techniques, Bancroft, J.D. and M. Gamble (Eds.). 5th Edn., Churchill Livingstone, London, New York, pp: 130.
7. Gwavava, N.J., OR. Pmkerton, J.F. Glasgow, J.M. Sloan and J.M. Bridges, 1981. Small bowel enterocyte abnormalities caused by methotrexate treatment in acute lymphoblastic leukaemia of childhood. J. Clm. Pathol, 34: 790-795.
8. Hapani, S, D. Chu and S. Wu, 2010. Eosinophilic pneumonia associated with bleomycin in a patient with mediastinal seminoma: A case report. J. Med. Case Rep, Vol. 4. 10.1186/1752-1947-4-126
9. Kolli, V.K, P. Abraham and S. Rabi, 2008. Methotrexate-induced nitrosative stress may play a critical role in small intestinal damage in the rat. Archiv. Toxicol, 82: 763-770.
10. Labejof, L, I. Mororo, P. Galle, G. Barbosa, M.I. Severo and A.H. de Oliveira, 2010. Effect of dose rate of irradiation on ultrastructure of duodenal mucosa. World Acad. Sci. Eng. Technol, 68: 664-671.
11. Lalla, R.V. and D.M.K. Keefe, 2011. Mucositis (Oral and Gastrointestinal). In: The MASCC Textbook of Cancer Supportive Care and Survivorship, Oliver, I.N. (Ed.). Springer, New York, pp: 241-248.
12. Leitao, R.F., R.A. Ribeiro, A.M. Lira, L.R. Silva and E.A. Bellaguarda et al., 2008. Glutamine and alanyl-glutamine accelerate the recovery from 5-fluorouracil-induced experimental oral mucositis in hamster. Cancer Chemother. Pharmacol., 61: 215-222.
13. Levine, S. and A. Saltzman, 2004. Hydropic degeneration of the anterior pituitary gland (adenohypophysis) in uremic rats. Toxicol. Lett., 147: 121-126.
14. Logan, R.M, A.M. Stringer, J.M. Bowen, R.J. Gibson, S.T. Soms and D.M.K. Keefe, 2009. Is the pathobiology of chemotherapy-induced alimentary tract mucositis influenced by the type of mucotoxic drug administered? Cancer Chemother. Pharm., 63: 239-251.
15. Longley, D.B., D.P. Harkin and P.G. Johnston, 2003. 5-fluorouracil: Mechanisms of action and clinical strategies. Nat. Rev. Cancer, 3: 330-338.
16. Magne, N., P.Y. Marcy, E. Chamorey, E. Guardiola and X Pivot et al., 2001. Concomitant twice-a-day radiotherapy and chemotherapy in unresectable head and neck cancer patients: A long-term quality of life analysis. Head Neck, 23: 678-682.
17. McCarthy, G.M., J.D. Awde, H. Ghandi, M. Vincent and W.I. Kocha, 1998. Risk factors associated with mucositis in cancer patients receiving 5-fluorouracil. Oral Oncol., 34: 484-490.
18. Pritchard, D.M., C.S. Potten and J.A. Hickman, 1998. The relationships between p53-dependent apoptosis, inhibition of proliferation and 5-fluorouracil-induced histopathology in murine intestinal epithelia. Cancer Res., 58: 5453-5465.
19. Soares, P.M.G, J.M.S.C. Mota, A.S. Gomes, R.B. Ohveira and A.M.S. Assreuy et al, 2008. Gastrointestinal dysmotility in 5-fluorouracil-induced intestinal mucositis outlasts inflammatory process resolution. Cancer Chemother. Pharmacol., 63: 91-98.
20. Soares, P.M.G, R.C.P. Lima-Junior, J.M.S.C. Mota, P.F.C. Justino and G.A.C. Brito et al, 2011. Role of platelet-activating factor in the pathogenesis of 5-fluorouracil-induced intestinal mucositis in mice. Cancer Chemother. Pharmacol, 68: 713-720.
21. Somosy, Z, 2000. Radiation response of cell organelles. Micron, 31: 165-181.
22. Somosy, Z, G. Horvath, A. Telbisz, G. Rez and Z. Palfia, 2002. Morphological aspects of ionizing radiation response of small intestine. Micron, 33: 167-178.
23. Sonis, S.T, 2010. Regimen-related gastrointestinal toxicities in cancer patients. Curr. Opin. Support. Palhat. Care, 4: 26-30.
24. Stringer, A.M., R.J. Gibson, R.M. Logan, J.M. Bowen, A.S. Yeoh, J. Hamilton and D.M. Keefe, 2009. Gastrointestinal microflora and mucins may play a critical role in the development of 5-fluorouracil-induced gastrointestinal mucositis. Exp. Biol. Med, 234: 430-441.
25. Torres, D.M, KL. Tooley, R.N. Butler, C.L. Smith, M.S. Geier and GS. Howarth, 2008. Lyprmol™ only partially improves indicators of small intestinal integrity in a rat model of 5-fluorouracil-induced mucositis. Cancer Biol. Ther, 7: 295-302.
26. Totty, B.A, 2002. Mucins. In: Theory and Practice of Histological Techniques, Bancroft, J.D. and M. Gamble (Eds.). 5th Edn. Churchill Livingstone, London, New York, pp: 175.
27. Woods, A.E. and J.W. Stirling, 2008. Electron Microscopy. In: Theory and Practice of Histological Techniques, Bancroft, J.D. and M. Gamble (Eds.). 6th Edn, Churchill Livingstone, London, New York, pp: 601-636.
28. Yanez, J.A, X.W. Teng, K.A. Roupe, M.W. Fariss and N.M. Davies, 2003. Chemotherapy induced gastrointestinal toxicity in rats: Involvement of mitochondrial DNA, gastrointestinal permeability and cyclooxygenase-2. J. Pharm. Pharm. Sci, 6: 308-314.